Idiopathic CD4+ lymphocytopenia

Clinical trials for Idiopathic CD4+ lymphocytopenia explained in plain language.

Never miss a new study

Get alerted when new Idiopathic CD4+ lymphocytopenia trials appear

Sign up with your email to follow new studies for Idiopathic CD4+ lymphocytopenia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

Scientists launch Long-Term study to unravel mysterious immune condition

Knowledge-focused Recruiting now

This study follows 950 people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where low CD4+ white blood cells raise infection risk. Researchers will track participants for up to 10 years, collecting medical history, blood samples, and infection data. The goal is to …

Matched conditions: IDIOPATHIC CD4+ LYMPHOCYTOPENIA

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused

Last updated Sep 02, 2026 00:00 UTC

Idiopathic CD4+ lymphocytopenia

Get alerted when new Idiopathic CD4+ lymphocytopenia trials appear

Scientists launch Long-Term study to unravel mysterious immune condition